Patent · US Active

Kit with stabilized thrombin

US10159719B2 · kind B2 · utility

0Cited by
18References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 20, 2015
Grant dateDec 25, 2018
Priority date
Expiry dateAug 20, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/974
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to compounds, methods for stabilizing thrombin activity with a thrombin binding oligonucleotide and to stabilized thrombin. The thrombin binding oligonucleotide is capable of inhibiting thrombin activity whereby the inhibition can be reversed with an antisense oligonucleotide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.